The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - Amgen; Bristol-Myers Squibb; Celgene; Janssen; Takeda
Consulting or Advisory Role - Amgen; Celgene; Janssen
Speakers' Bureau - Celgene; Janssen
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb; Celgene; Janssen; Takeda
 
Consulting or Advisory Role - Celgene; Janssen; Takeda
Research Funding - Celgene; Janssen; Takeda
Upfront autologous stem cell transplantation (ASCT) versus novel agent-based therapy for multiple myeloma (MM): A randomized phase 3 study of the European Myeloma Network (EMN02/HO95 MM trial).
 
Michele Cavo
No Relationships to Disclose
 
Antonio Palumbo
Honoraria - Amgen; Bristol-Myers Squibb; Celgene; Genmab; Janssen-Cilag; Millennium; Novartis; Onyx; Sanofi
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Celgene; Genmab; Janssen-Cilag; Millennium; Onyx
 
Sonja Zweegman
No Relationships to Disclose
 
Meletios A. Dimopoulos
Honoraria - Amgen; Celgene; Janssen; Novartis
Consulting or Advisory Role - Amgen; Celgene; Janssen; Novartis
 
Roman Hajek
Honoraria - Amgen
Consulting or Advisory Role - Amgen; Celgene; Janssen; Takeda
 
Lucia Pantani
No Relationships to Disclose
 
Meral Beksac
Consulting or Advisory Role - Amgen; Celgene; Janssen-Cilag; Novartis; Takeda
Speakers' Bureau - Amgen; Bristol-Myers Squibb; Celgene; Janssen-Cilag
 
Ruth Wester
No Relationships to Disclose
 
Hans E. Johnsen
No Relationships to Disclose
 
Ulf-Henrik Mellqvist
Honoraria - Amgen; Celgene; Mundipharma; Novartis
Consulting or Advisory Role - Amgen; Takeda
Research Funding - Celgene; Janssen; Oncopeptides
 
Maria Teresa Petrucci
Honoraria - Bristol-Myers Squibb; Celgene; Janssen-Cilag; Mundipharma; Sanofi; Takeda
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Takeda
 
Christoph Driessen
No Relationships to Disclose
 
Francesco Di Raimondo
Consulting or Advisory Role - ARIAD; Bristol-Myers Squibb; Novartis; Roche
Speakers' Bureau - Bristol-Myers Squibb; Celgene; Novartis
Travel, Accommodations, Expenses - Gilead Sciences
 
Rossella Troia
No Relationships to Disclose
 
Annalisa Pezzi
No Relationships to Disclose
 
Bronno van der Holt
No Relationships to Disclose
 
Ka Lung Wu
Consulting or Advisory Role - Karyopharm Therapeutics
Travel, Accommodations, Expenses - Celgene
 
Heinz Ludwig
Honoraria - Amgen; Bristol-Myers Squibb; Celgene; Janssen; Novartis; Onyx
Consulting or Advisory Role - Boehringer Ingelheim; Janssen
Speakers' Bureau - Amgen; Bristol-Myers Squibb; Celgene; Janssen; Novartis; Onyx
Research Funding - Takeda
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb; Celgene; Janssen; Novartis; Onyx
 
Francesca Gay
Honoraria - Celgene; Janssen
Consulting or Advisory Role - Janssen; Mundipharma; Takeda
 
Pieter Sonneveld
Honoraria - Amgen; Bristol-Myers Squibb; Celgene; Janssen; Novartis
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Celgene; Janssen
Research Funding - Amgen; Celgene; Janssen